LEADER 05246nam 2201657z- 450 001 9910585940103321 005 20231214133646.0 035 $a(CKB)5600000000483081 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/91187 035 $a(EXLCZ)995600000000483081 100 $a20202208d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPharmacy Practice and Administration 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 electronic resource (260 p.) 311 $a3-0365-4730-4 311 $a3-0365-4729-0 330 $aThe scope of the Special Issue is research and reviews on evaluations of current practice, innovations in medication management, developments in therapeutics, and pharmaceutical science research that informs and improves practice and administration, as well as the social and administrative pharmacy. We will mainly feature original research, reviews, short reports, and clinical studies, but also case reports, descriptive/how-to, and commentary submissions for consideration. 606 $aMedicine$2bicssc 606 $aPharmaceutical industries$2bicssc 610 $aolder adults 610 $apolypharmacy 610 $ainternal medicine ward 610 $acommunity pharmacy 610 $adrug disposal 610 $aunused medication 610 $aenvironment 610 $aawareness 610 $apractice 610 $aambulatory care facilities 610 $ahealth workforce 610 $apharmacists 610 $aTaiwan 610 $aCommonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) 610 $aNational Health Service (NHS) 610 $aChief Pharmaceutical Officer?s Global Health Fellowship 610 $aCPhOGH Fellows 610 $aCwPAMS 610 $apharmacy 610 $afellowship 610 $ahealth partnerships 610 $aantimicrobial resistance (AMR) 610 $aglobal health 610 $aleadership 610 $anon-prescription medicines 610 $aemergency contraception 610 $acommunity pharmacies 610 $ainformation gathering 610 $aavailability 610 $apricing 610 $amystery calls 610 $aulipristal acetate 610 $alevonorgestrel 610 $aGermany 610 $ae-prescription 610 $aprescription writing 610 $aJazan 610 $aSaudi Arabia 610 $aprescription errors 610 $amedicine consumption 610 $adefined daily dose 610 $aadolescents and young adults 610 $acancer patients 610 $afragility 610 $apain 610 $aMUR 610 $amedication review 610 $abarriers 610 $apharmacist 610 $apregabalin 610 $aabuse 610 $acommunity pharmacists 610 $areproductive health 610 $acontraception 610 $aemergency contraceptives 610 $apatient education 610 $abiosensing technology 610 $adigital medicine system 610 $amedication adherence 610 $amedication event monitoring system 610 $anonadherence 610 $aprescription opioids 610 $amortality 610 $astandardized mortality ratio 610 $aunderlying cause of death 610 $aprescriptions 610 $acommunity pharmacy services 610 $aemergency prescribing 610 $apharmacy practice 610 $apharmacy law and regulation 610 $aCOVID-19 610 $aadditional monitoring 610 $ablack triangle 610 $aadverse event reporting 610 $apharmacovigilance 610 $aintervention 610 $aoutcomes 610 $asystematic review 610 $apharmacy education 610 $adecision to study in pharmacy 610 $aselecting pharmacy as a first choice 610 $apharmacogenomics 610 $alearning activity 610 $aasynchronous learning 610 $avirtual learning 610 $astudent survey 610 $aProgram of All-Inclusive Care for the Elderly 610 $aadverse drug events 610 $amedication-related problems 610 $adrug-related problems 610 $amedication safety 610 $aMedicare 610 $aMedicaid 610 $afinancial management 610 $apharmacy management 610 $abusiness 610 $aentrepreneurship 610 $apharmacy students 610 $aperception 610 $aattitudes 610 $aability 610 $ainterprofessional 610 $asimulation 610 $aacute care 610 $anursing 610 $astudents 610 $astandardized patients 610 $ahigh fidelity 610 $aSPICE-R2 615 7$aMedicine 615 7$aPharmaceutical industries 700 $aAdunlin$b Georges$4edt$01328216 702 $aAdunlin$b Georges$4oth 906 $aBOOK 912 $a9910585940103321 996 $aPharmacy Practice and Administration$93038436 997 $aUNINA